WO2010118188A3 - Production of an intact virus in a non-host cell system using a secondary host viral construct - Google Patents
Production of an intact virus in a non-host cell system using a secondary host viral construct Download PDFInfo
- Publication number
- WO2010118188A3 WO2010118188A3 PCT/US2010/030314 US2010030314W WO2010118188A3 WO 2010118188 A3 WO2010118188 A3 WO 2010118188A3 US 2010030314 W US2010030314 W US 2010030314W WO 2010118188 A3 WO2010118188 A3 WO 2010118188A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- production
- host
- cell system
- viral construct
- host cell
- Prior art date
Links
- 241000700605 Viruses Species 0.000 title abstract 3
- 230000003612 virological effect Effects 0.000 title abstract 3
- 241000701447 unidentified baculovirus Species 0.000 abstract 2
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 abstract 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 229960004854 viral vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/101—Bovine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/02—Animal zootechnically ameliorated
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/14011—Baculoviridae
- C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
- C12N2710/14141—Use of virus, viral particle or viral elements as a vector
- C12N2710/14144—Chimeric viral vector comprising heterologous viral elements for production of another viral vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/16011—Caliciviridae
- C12N2770/16041—Use of virus, viral particle or viral elements as a vector
- C12N2770/16043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24241—Use of virus, viral particle or viral elements as a vector
- C12N2770/24243—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32041—Use of virus, viral particle or viral elements as a vector
- C12N2770/32043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/60—Vector systems having a special element relevant for transcription from viruses
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Virology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
The present invention relates to constructs and methods for the production of recombinant proteins, viruses, and viral vaccines in heterologous culture systems by expressing intact genes or viral genomes under the control of a pantropic promoter in a culture system that is not considered a host to the virus so produced. The promoter/viral genome constructs are inserted into a baculovirus and expressed in host cells that are acceptable for infection by the baculovirus.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16765809P | 2009-04-08 | 2009-04-08 | |
US61/167,658 | 2009-04-08 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2010118188A2 WO2010118188A2 (en) | 2010-10-14 |
WO2010118188A3 true WO2010118188A3 (en) | 2011-03-17 |
Family
ID=42936869
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2010/030314 WO2010118188A2 (en) | 2009-04-08 | 2010-04-08 | Production of an intact virus in a non-host cell system using a secondary host viral construct |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2010118188A2 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8968721B2 (en) | 2005-12-28 | 2015-03-03 | Advanced Bionutrition Corporation | Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same |
US9504750B2 (en) | 2010-01-28 | 2016-11-29 | Advanced Bionutrition Corporation | Stabilizing composition for biological materials |
US9504275B2 (en) | 2010-08-13 | 2016-11-29 | Advanced Bionutrition Corporation | Dry storage stabilizing composition for biological materials |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1973406B1 (en) | 2005-12-28 | 2014-03-12 | Advanced Bionutrition Corporation | A delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form |
CA2673120C (en) | 2006-12-18 | 2012-08-07 | Advanced Bionutrition Corporation | A dry food product containing live probiotic |
ES2908047T3 (en) | 2009-03-27 | 2022-04-27 | Intervet Int Bv | Microparticle vaccines for oral or nasal vaccination and boosting of animals including fish |
NZ597053A (en) | 2009-05-26 | 2014-02-28 | Advanced Bionutrition Corp | Stable dry powder composition comprising biologically active microorganisms and/or bioactive materials and methods of making |
EP2529004B1 (en) | 2010-01-28 | 2017-06-07 | Advanced Bionutrition Corporation | Dry glassy composition comprising a bioactive material |
WO2011130125A1 (en) * | 2010-04-12 | 2011-10-20 | Viracine Therapeutics Corporation | Expression of positive sense single stranded rna virus and uses thereof |
WO2017019273A1 (en) | 2015-07-29 | 2017-02-02 | Advanced Bionutrition Corporation | Stable dry probiotic compositions for special dietary uses |
CN114292879B (en) * | 2021-12-30 | 2024-01-26 | 中国海洋大学 | Prawn virus expression system for delivering and expressing exogenous genes in prawns |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5681746A (en) * | 1994-12-30 | 1997-10-28 | Chiron Viagene, Inc. | Retroviral delivery of full length factor VIII |
WO2003048325A2 (en) * | 2001-12-04 | 2003-06-12 | University Of Hawaii | Nucleotide sequences of shrimp beta-actin and actin promoters and their use in genetic transformation technology |
US20040177392A1 (en) * | 2001-09-14 | 2004-09-09 | Ruth Barratt | Crustaceans as production systems for therapeutic proteins |
US20070292952A1 (en) * | 2004-04-15 | 2007-12-20 | Advanced Bionutrition Corporation | Crustacean Expression Vector |
-
2010
- 2010-04-08 WO PCT/US2010/030314 patent/WO2010118188A2/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5681746A (en) * | 1994-12-30 | 1997-10-28 | Chiron Viagene, Inc. | Retroviral delivery of full length factor VIII |
US20040177392A1 (en) * | 2001-09-14 | 2004-09-09 | Ruth Barratt | Crustaceans as production systems for therapeutic proteins |
WO2003048325A2 (en) * | 2001-12-04 | 2003-06-12 | University Of Hawaii | Nucleotide sequences of shrimp beta-actin and actin promoters and their use in genetic transformation technology |
US20070292952A1 (en) * | 2004-04-15 | 2007-12-20 | Advanced Bionutrition Corporation | Crustacean Expression Vector |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8968721B2 (en) | 2005-12-28 | 2015-03-03 | Advanced Bionutrition Corporation | Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same |
US9504750B2 (en) | 2010-01-28 | 2016-11-29 | Advanced Bionutrition Corporation | Stabilizing composition for biological materials |
US9504275B2 (en) | 2010-08-13 | 2016-11-29 | Advanced Bionutrition Corporation | Dry storage stabilizing composition for biological materials |
Also Published As
Publication number | Publication date |
---|---|
WO2010118188A2 (en) | 2010-10-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2010118188A3 (en) | Production of an intact virus in a non-host cell system using a secondary host viral construct | |
WO2010118205A3 (en) | Production of an intact virus in a mammalian (non-host) cell system using a secondary non-host viral construct | |
HRP20211015T1 (en) | Cmv vaccines | |
WO2007097820A3 (en) | Viral gene products and methods for vaccination to prevent viral associated diseases | |
PH12015500931A1 (en) | Recombinant particle based vaccines against human cytomegalovirus infection | |
WO2011048353A3 (en) | Construct for production of empty picornaviral capsids | |
EA201791343A1 (en) | COMPOSITIONS AND METHODS FOR CONSTRUCTING A VIRUS GENOME IN VITRO | |
CA3050271A1 (en) | Baculovirus-based production of biopharmaceuticals free of contaminating baculoviral virions | |
MX346245B (en) | Fusion protein comprising diphtheria toxin non-toxic mutant crm197 or fragment thereof. | |
WO2012171026A3 (en) | Methods for high yield virus production | |
WO2008099189A3 (en) | Herpes simplex viruses and methods of viral replication | |
WO2013096866A3 (en) | Processes using vlps with capsids resistant to hydrolases | |
NZ612603A (en) | Virus like particle production in plants | |
WO2011153351A3 (en) | Novel modified live-attenuated vaccines (mlv) and subunit vaccines created by dna shuffling against porcine reproductive and respiratory syndrome virus (prrsv) | |
RU2012142309A (en) | RECOMBINANT ATTENUATED PARVOVIRUS | |
IN2012DN03823A (en) | ||
DK2608806T3 (en) | EPSTEIN-BARR VIRUS VACCINE | |
WO2011072247A3 (en) | Pathogen restriction factors | |
WO2008148104A8 (en) | Novel vlps derived from cells that do not express a viral matrix or core protein | |
WO2013091661A3 (en) | Proteolytic resistant protein affinity tag | |
WO2011022656A3 (en) | Recombinant avian paramyxovirus vaccine and method for making and using thereof | |
WO2012115474A3 (en) | Novel varicella-zoster virus strains, and chicken pox and herpes zoster virus vaccine using same | |
RS54933B1 (en) | Herpes simplex virus vaccines | |
MY162335A (en) | Viral particle released after infection of mammalian cells by human cytomegalovirus (hcmv) containing a fusion protein and use thereof | |
WO2014122629A3 (en) | Improved baculoviral expression system and methods of producing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 10762414 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 10762414 Country of ref document: EP Kind code of ref document: A2 |